Platelet count at diagnosis predicts survival in children with acute lymphoblastic leukemia

Víctor H Olivares-Villalpando1,2, José G Peñaloza-González1, Martha M Velázquez-Aviña1

  • 1Servicio de Onco Hemato Pediatría, Hospital Juárez de México, Secretaría de Salud.

Gaceta Medica De Mexico
|July 20, 2026
PubMed

Insights

In pediatric acute lymphoblastic leukemia, a higher initial platelet count is linked to improved survival. This finding is independent of other known prognostic factors, aiding in risk stratification.

Area of Science:

  • Pediatric Oncology
  • Hematology
  • Leukemia Research

Background:

  • Prognostic variables in pediatric acute lymphoblastic leukemia (ALL) guide treatment strategies.
  • Risk stratification is crucial for optimizing patient outcomes in ALL.

Purpose of the Study:

  • To determine the association between initial platelet count and survival in pediatric ALL patients.
  • Investigate the prognostic value of platelet count at diagnosis.

Main Methods:

  • Comparative survival analysis of pediatric ALL patients based on initial platelet count.
  • Utilized Kaplan-Meier curves and Cox regression analysis.
  • Defined a cut-off of 50 × 10^9/L for platelet count groups.

Main Results:

  • Higher initial platelet counts (> 50 × 10^9/L) correlated with a better prognosis (p=0.002).
  • Multivariate Cox regression confirmed initial platelet count as an independent predictor of overall survival (p=0.025, HR: 1.42).

Conclusions:

  • Initial platelet count is a significant, independent prognostic factor in pediatric ALL.
  • Platelet count at diagnosis directly impacts patient survival.
  • This marker can refine risk assessment and treatment planning for childhood ALL.
Abstract

Related Concept Videos